Question

Compare catabolism of purine and pyrimidine nucleotides

08 Feb 2025
Answer :
Word Count : 543

The catabolism of purine and pyrimidine nucleotides involves distinct biochemical pathways, reflecting their structural differences and metabolic processes in the body. Both nucleotides play essential roles in cellular functions, including DNA and RNA synthesis, but their degradation pathways diverge significantly.

Purine Nucleotide Catabolism:

Purines, such as adenine and guanine, are broken down into various metabolites before being excreted. The catabolic process starts with the conversion of nucleotides (AMP and GMP) into their respective nucleosides, adenosine and guanosine. Adenosine undergoes deamination by the enzyme adenosine deaminase, converting it to inosine. Inosine is then hydrolyzed to produce hypoxanthine. Guanosine, on the other hand, is deaminated by guanosine deaminase to form xanthine. Both hypoxanthine and xanthine are further oxidized by the enzyme xanthine oxidase to produce uric acid, which is excreted from the body.

The catabolism of purines can lead to the formation of

________ ____ _________ _____ ______ _________ ____.
___ _____ _________ __________ ___ _____ _______ ___ __________ ________ _________ ________.
___ _______ _____ _____ ____ __________ ________.
__________ ____ ___ _________ ______ _________ ______ ___.
_________ _________ ______ _________ ________ ________ __________.
______ ____ ___ ____ __________ _____.
____ __________ __________ ___ ____ __________ _______.
__________ _______ ______ ______ __________ ___ ________ ________.
_____ _________ _____ __________ ________ ________ ___ _____ ________ ___ _______ _________.
___ _________ _______ __________ _____.
____ _____ ________ _______ _______ ___ ________ _________ _____ ________ ___.
_______ __________ ______ ____ ________ ___ ______ ___ _________ ________.
____ ________ _______ _________ ______.
_______ ___ _____ ___ ___ ______.
__________ _________ __________ __________ ______ __________ ________.
________ ___ ________ _________ _____ _________ ______ ___ ____ _______.
________ ___ ________ _____ _______ _____ _______ ____ _______ ________ ___ ________.
___ __________ _________ _____ ______ _________ ____ ______ ________.
___ _______ ________ _____ _____ ___ ________ _________ ___ _____ _____ __________.
___ __________ ____ __________ _______.
________ ___ __________ _____ _______ ___ ___.
___ ______ _________ _________ _________ ___ ______ __________.
_______ _________ _______ __________ _____ _____ ______ _________ _________ ______.
_______ ___ ____ ________ ___ ________ ______.
_________ ___ ________ ________ ___ _________ __________ ___ __________ _________ ___.
_____ _____ __________ ______ ___ ________ __________ _________ _______ _________ ________.
__________ ___ _____ _____ _________ ____ _______ ___.
___ ____ _______ __________ ___ ________.
__________ _____ _____ ___ _______ _____ ____.
_________ __________ ______ _________ ____ ________ _________.
______ __________ ____ _______ __________ ____ ________ __________.
_____ _____ _____ ___ ____.
_____ ___ _______ __________ ________ ______ _________ _________.
______ ___ _________ ____ ______ _________ ___ __________ _________.
________ __________ ________ ___ _______ ________ ______.
_______ ____ ________ ____ ____ _______ _______ _________ ___.
________ ___ _____ ____ _________ ____ ______ ______ ______ __________ _____ ___.
___ ____ ________ ______ _____.
____ _________ ______ ________ _______ ___ _________.
__________ ______ _________ _________ _________ _____ _________ ______.
______ ____ _____ ___ ____ _______ ______ _________ _______ _____ _____.
__________ __________ _______ _______ ______ __________ ____ _______.
______ _______ ______ ________ _____ ______ _____ _______ _____ ________ ___ __________.
__________ _____ _____ _____ __________ _________ _________ _________ ___.
________ ________ _______ _________ _________ ______.
___ __________ _________ ___ _________ _______ ___ ____ __________ ____ _____ _________.
__________ _______ _____ _______ ___ ____ _______ ______ ______.
______ __________ ____ ___ __________.
_______ _______ ___ _______.
IGNOU ACADEMY
Your IGNOU journey, made easier.
  • Solved Assignments
  • Study Notes
  • Guess Papers
  • Question Papers
Skip in 10
Top
📞
Call Support Instant phone assistance IGNOU BBCCT 113 2025 - Compare catabolism of purine and pyrimidine nucleotides | IGNOU Academy
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→